Most Recent
A former solicitor with Sydney law firm Atanaskovic Hartnell was jailed Wednesday for a minimum of three years in a fraud case a judge called a "sad illustration of the moral delinquency" of online betting in Australia.
A Queens Counsel and a junior barrister at the Victorian Bar are taking DLA Piper to court, accusing the law firm of failing to pay more than $370,000 in fees.
The Australian distributor of Atomic coffee machines has lost a Federal Court appeal of an IP Australia decision allowing the registration of the Atomic trade mark by a South Perth cafe, with a judge slamming her evidence on the stand as untruthful.
Australia's four biggest lenders had an expensive year in court last year, but with cases spilling over into the new year and the fallout from the Royal Commission expected to see a litigation blitz by regulators and class action lawyers, much more is in store for the banks in 2019. Here, Lawyerly takes a look at the court cases facing ANZ Banking Group, Commonwealth Bank of Australia, National Australia Bank and Westpac Banking Corp so far this year.
Two law firms have launched formal investigations into possible class actions over Sydney's defective Opal Tower, inviting owners of units in the "crumbling" building to register their interest in joining legal proceedings.
The families of asylum seekers who died in the 2010 Christmas Island boat crash have lost an appeal of a ruling that dismissed their class action against Australia.
An independent expert panel who will determine a 'Best in Show' shortlist of super funds would take over from unions and employers in controlling Australia's default superannuation system as part of a major overhaul of the $2.7 trillion industry recommended Thursday.
A judge has rejected an application by auto electronics maker Redarc Group for an injunction in a case against rival B8 Systems over an innovation patent for its flagship vehicle brake controller, despite its strong case of infringement.
Generic drug maker Sandoz is challenging a ruling that it infringed a patent behind Lundbeck's blockbuster antidepressant Lexapro, reviving a 15-year fight over the lucrative intellectual property.
A judge who signed off on a contested $36.5 million settlement to resolve a $1 billion class action against Slater & Gordon has explained his reasons a year later, saying the "unusual" deal flowed from the law firm's "dire financial situation".